Scientists evaluated longitudinal immune responses to two-dose BNT162b2 mRNA vaccination in 15 adults who had experienced COVID-19, compared to 21 adults who did not have prior COVID-19.
[Science Translational Medicine]
6445212
CCCCCCCC
items
1
apa
0
default
asc
1
169788
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
